Frontiers in Cardiovascular Medicine | Lipids in Cardiovascular Disease

Review

Accepted on 17 Feb 2025

Crosstalk Between Lipid Metabolism and Macrophages in Atherosclerosis: Therapeutic Potential of Natural Products

in Lipids in Cardiovascular Disease

Taoming Qian
Donghao Guo
Lu Sun
Ming Chi
Xiaoshuang Ma
Juan Jin

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1529924

Opinion

Accepted on 14 Feb 2025

Fatigued with Friedewald: Why Isn't Everyone Onboard Yet with the New LDL-C Equations?

in Lipids in Cardiovascular Disease

Madhusudhanan Narasimhan
Jing Cao
Jeffrey Meeusen
Alan Remaley
Seth Shay Martin
Alagarraju MUTHUKUMAR

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1534460

Brief Research Report

Published on 14 Feb 2025

Deficient perceptions and practices concerning elevated lipoprotein(a) among specialists in Singapore

in Lipids in Cardiovascular Disease

Wann Jia Loh
Jing Pang
Oliver Simon
Dick C. Chan
Gerald F. Watts

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1527351

345 views

Original Research

Published on 12 Feb 2025

Body mass index impacts the lipid-lowing effects of statins in patients with type 2 diabetes

in Lipids in Cardiovascular Disease

Lulu Sun
Zhuo Wang
Bai Wang
Yuxiang Jia
Qidi Zhao
Jingjun Zhao
Xingtao Huang

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1493613

144 views

Original Research

Accepted on 05 Feb 2025

Dietary and Lifestyle Oxidative Balance Scores and Their Impact on Cardiovascular Diseases: Exploring the Mediating Influence of Hepatic Function and Blood Lipid Levels

in Lipids in Cardiovascular Disease

Yi He
Ying Lan

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1493271

Mini Review

Published on 05 Feb 2025

Call for a consensual definition of dyslipidemia in coronary angiography trials

in Lipids in Cardiovascular Disease

Aurélien Clerc
Mario Togni
Stephane Cook

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1506149

304 views

Systematic Review

Published on 05 Feb 2025

Efficacy and safety of PCSK9 inhibitors, potent statins, and their combinations for reducing low-density lipoprotein cholesterol in hyperlipidemia patients: a systematic network meta-analysis

in Lipids in Cardiovascular Disease

Yuhua Jiang
Yingying Wang
Sijia Ma
Linlin Qian
Yeteng Jing
Xi Chen
Jinsheng Yang

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1415668

348 views

Editorial

Published on 23 Jan 2025

Editorial: Women in lipids in cardiovascular disease

in Lipids in Cardiovascular Disease

Irena Levitan
Catherine Martel

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1547089

326 views

Original Research

Accepted on 10 Jan 2025

Association of accumulated exposure to non-high-density lipoprotein cholesterol concentration with risk of premature cardiovascular disease: the Kailuan Study

in Lipids in Cardiovascular Disease

Yifei Wang
Xuemei Zhao
Haibo Gao
Wei Li
Haotian Wu
Guiping Wang
Xiaokun Liu
Shouling Wu

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1480566

Hypothesis and Theory

Published on 10 Jan 2025

U-shaped association between the non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and mortality risk in obese adults: evidence from NHANES 1999–2018

in Lipids in Cardiovascular Disease

Zi Lin
Tao Yi
Feng Hu
Jinhua Chen
Lianglong Chen

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1524465

587 views

Mini Review

Published on 06 Jan 2025

Bile acids and incretins as modulators of obesity-associated atherosclerosis

in Lipids in Cardiovascular Disease

Andrijana Kirsch
Juergen Gindlhuber
Diana Zabini
Elena Osto

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1510148

648 views

Original Research

Published on 06 Jan 2025

Association between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and telomere length: the NHANES 1999–2002

in Lipids in Cardiovascular Disease

Mingjie Liu
Chendong Wang
Bai Wei

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1407452

1,056 views

Original Research

Published on 23 Dec 2024

A non-linear association of low-density lipoprotein cholesterol with all-cause and cardiovascular mortality among patients with hypertension

in Lipids in Cardiovascular Disease

Guoliang Liang
Wenhao Zhang
Xinxin Gu
Qiong Zhang
Ankang Liu
Xinran Qing
Jiangwei Ma

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1469848

765 views

Original Research

Published on 19 Dec 2024

Body mass index mediates the association between plasma lipid concentrations and the prevalence of obstructive sleep apnea among US adults: a cross-sectional study

in Lipids in Cardiovascular Disease

Xiao Hu
Jing Xu
Yang Gu

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1433884

946 views

Review

Published on 09 Dec 2024

Cerebrotendinous xanthomatosis: a literature review and case study

in Lipids in Cardiovascular Disease

Anthony Matta
Fabienne Ory Magne
Thierry Levade
Fabrice Bonneville
Jean Ferrières

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1496442

854 views

Review

Published on 06 Dec 2024

Atherogenic circulating lipoproteins in ischemic stroke

in Lipids in Cardiovascular Disease

Sonia Benitez
Núria Puig
Pol Camps-Renom
José Luis Sánchez-Quesada

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1470364

835 views

Navigation group

Articles

Crosstalk Between Lipid Metabolism and Macrophages in Atherosclerosis: Therapeutic Potential of Natural Products

Fatigued with Friedewald: Why Isn't Everyone Onboard Yet with the New LDL-C Equations?

Deficient perceptions and practices concerning elevated lipoprotein(a) among specialists in Singapore

Body mass index impacts the lipid-lowing effects of statins in patients with type 2 diabetes

Dietary and Lifestyle Oxidative Balance Scores and Their Impact on Cardiovascular Diseases: Exploring the Mediating Influence of Hepatic Function and Blood Lipid Levels

Call for a consensual definition of dyslipidemia in coronary angiography trials

Efficacy and safety of PCSK9 inhibitors, potent statins, and their combinations for reducing low-density lipoprotein cholesterol in hyperlipidemia patients: a systematic network meta-analysis

Editorial: Women in lipids in cardiovascular disease

Association of accumulated exposure to non-high-density lipoprotein cholesterol concentration with risk of premature cardiovascular disease: the Kailuan Study

U-shaped association between the non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and mortality risk in obese adults: evidence from NHANES 1999–2018

Bile acids and incretins as modulators of obesity-associated atherosclerosis

Association between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and telomere length: the NHANES 1999–2002

A non-linear association of low-density lipoprotein cholesterol with all-cause and cardiovascular mortality among patients with hypertension

Body mass index mediates the association between plasma lipid concentrations and the prevalence of obstructive sleep apnea among US adults: a cross-sectional study

Cerebrotendinous xanthomatosis: a literature review and case study

Atherogenic circulating lipoproteins in ischemic stroke